Breast cancer.
Hartmann
L C
LC
Loprinzi
C L
CL
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000523:psychology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D008403:Mass Screening; D011379:Prognosis; D011956:Receptors, Cell Surface / Q000032:analysis; D012307:Risk Factors
D000970:Antineoplastic Agents; D006133:Growth Substances; D011956:Receptors, Cell Surface